06/05/2026
Chemotherapy is standard for nasopharyngeal cancer, but it often comes with challenging side effects. Now that an immunotherapy is approved for this type of cancer, patients may get similar outcomes with less chemo. Cancer Today looks at what this could mean for patient care: https://brnw.ch/21x37m8